Concepedia

Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)

Michele Ghielmini, Kaspar Rufibach, Gilles Salles, L. Leoncini-Franscini, Claire Falandry, Sergio Cogliatti, Martin F. Fey, Giovanni Martinelli, Rolf A. Stahel, Andreas Lohri,

Annals of Oncology · 2005 · 161 citations · 8 references

DOIFull text

Open access

Concepts

References

8

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene

Guillaume Cartron, Laurent Dacheux, Gilles Salles et al. · Blood · 2002 · 1.9K citations · Full text

Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule

Michele Ghielmini · Blood · 2004 · 567 citations · Full text

Polymorphisms in FcγRIIIA (CD16) Receptor Expression Are Associated With Clinical Response to Rituximab in Waldenström’s Macroglobulinemia

Steven P. Treon, Mark Hansen, Andrew R. Branagan et al. · Journal of Clinical Oncology · 2005 · 255 citations · Full text

FcγRIIIa and FcγRIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia

Sherif S. Farag, Ian W. Flinn, Rama Modali et al. · Blood · 2003 · 206 citations · Full text

Effect of Single-Agent Rituximab Given at the Standard Schedule or As Prolonged Treatment in Patients With Mantle Cell Lymphoma: A Study of the Swiss Group for Clinical Cancer Research (SAKK)

Michele Ghielmini, Shu‐Fang Hsu Schmitz, Sergio Cogliatti et al. · Journal of Clinical Oncology · 2004 · 197 citations · Full text